Next Article in Journal
Exploring Marine-Derived Antioxidant and Anti-Inflammatory Agents: Findings from Recent Studies
Next Article in Special Issue
Catechol Siderophores from a Mangrove-Derived Bacteria Serratia marcescens F2-2 and Their Cytotoxic Activity
Previous Article in Journal
The Conopeptide αD-FrXXA, an Inhibitor of Voltage-Gated Potassium Channels
Previous Article in Special Issue
New Bioactive Polyketides from the Mangrove-Derived Fungus Penicillium sp. SCSIO 41411
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

New Bioactive Polyketides from the Mangrove-Derived Fungus Daldinia eschscholzii HJX1P2

1
Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou 571158, China
2
Key Laboratory of Tropical Medicinal Plant Chemistry of Hainan Province, Haikou 571158, China
3
International Center for Aging and Cancer, Hainan Medical University, Haikou 571158, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2025, 23(6), 238; https://doi.org/10.3390/md23060238
Submission received: 4 May 2025 / Revised: 28 May 2025 / Accepted: 29 May 2025 / Published: 30 May 2025
(This article belongs to the Special Issue Advances in Secondary Metabolites from Mangrove Holobiont)

Abstract

Three new naphthalene–chroman dimer derivatives, daldinaphchromes A–C (13), two new chroman derivatives, daldichromes A (5) and B (6), along with five known compounds (4, 710) were isolated from the mangrove-derived fungus Daldinia eschscholzii HJX1P2. Their structures and stereochemistries were elucidated through detailed NMR and MS analyses, calculated electronic circular dichroism, and comparison with previously reported data. Compound 1 demonstrated inhibitory effects on nitric oxide (NO) production in LPS-induced RAW 264.7 cells, with an IC50 value of 62.9 µM, and more effectively suppressed the expression of interleukin (IL)-6 than dexamethasone. A further mechanistic study suggested that 1 could prohibit the expression of iNOS in RAW 264.7 cells, and the molecular docking study suggested a possible interaction between 1 and the iNOS protein. Compounds 7 and 8 exhibited moderate to potent DPPH radical scavenging activity, with IC50 values of 117.4 and 46.2 µM, respectively, compared with the positive control ascorbic acid (IC50 = 45.6 µM). Compounds 4 and 10 showed ABTS+ radical scavenging activity, with IC50 values of 66.6 and 33.2 µM, respectively, which were equal to or lower than that of the positive control vitamin C (IC50 = 59.7 µM). Compounds 13, 7, and 9 showed antibacterial activity against three Staphylococcus aureus strains, with MIC values of 74.4–390.6 μM.

1. Introduction

Mangroves, as highly productive ecosystems widely distributed along tropical and subtropical coasts, harbor rich microbial resources, and have a significant role in altering microbial communities and nutrient cycles [1]. Mangrove fungi are considered to be an underexplored source of novel bioactive compounds, which meet the need of confronting new multidrug-resistant pathogens [2,3,4,5,6,7]. Among them, the genus Daldinia has shown great potential in medicine, environmental protection, and agriculture, emerging as a promising source for bioactive compound discovery. From January 1995 to June 2024, 280 metabolites, including 196 new compounds and 112 bioactive compounds, were obtained from the genus Daldinia [7,8,9]. Daldinia sp. isolated from mangroves produce a wide range of biologically active secondary metabolites, such as polyketides, alkaloids, polyphenols, and terpenoids [10,11,12,13].
During our ongoing investigations into the fungi inhabiting mangrove environments [14,15,16,17,18,19], the fermentation of the fungus Daldinia eschscholzii HJX1P2, collected from the Hainan Mangrove Conservation Area, displayed significant anti-inflammatory activity. The subsequent purification led to the discovery of three new naphthalene–chroman dimer derivatives, daldinaphchromes A–C (13), two new chroman derivatives, daldichromes A (5) and B (6), along with five known compounds, nodulisporin D (4) [20], 8-ethyl-7-hydroxy-2,3-dimethyl-4-oxo-chromene-5-carboxylic acid (7) [21], (2S)-2,3-dihydro-5,6-dihydroxy-2-methyl-4H-1-benzopyran-4-one (8) [22], 8-methoxynaphthalene-1,7-diol (9) [23], and 1-(2,6-dihydroxy-phenyl)butan-1-one (10) [24] (Figure 1). Herein, we report the isolation, structure elucidation, and bioactivity of these compounds.

2. Results and Discussion

2.1. Structural Determination

Compound 1 was isolated as a yellow gum. Its molecular formula was determined as C21H20O4 based on an HR-ESI-MS ion peak at m/z 335.1291 [M-H], appropriate for twelve degrees of unsaturation. The 1H NMR spectroscopic data (Table 1), combined with the HSQC spectrum of 1, showed two hydroxyl groups at δH 9.36 (1H, s, 5-OH) and 9.62 (1H, s, 8′-OH); eight aromatic protons at δH 6.60 (1H, d, J = 8.0 Hz, H-2), 6.80 (1H, d, J = 8.0 Hz, H-3), 6.84 (1H, d, J = 7.8 Hz, H-6), 7.45 (1H, t, J = 7.8 Hz, H-7), 7.70 (1H, d, J = 7.8 Hz, H-8), 6.35 (1H, d, J = 8.4 Hz, H-5′), 6.97 (1H, t, J = 8.4 Hz, H-6′), and 6.35 (1H, d, J = 8.4 Hz, H-7′); one oxygenated methine signal at δH 3.87 (1H, m, H-3′); one methoxyl group at δH 3.96 (3H, s, 4-OMe); one methine proton at δH 4.80 (1H, d, J = 5.6 Hz, H-1′); one methylene group at δH 1.95 (1H, ddd, J = 13.6, 11.6, 5.6 Hz, H-2′β) and 1.86 (1H, d, J = 13.6 Hz, H-2′α); and one methyl group at δH 1.18 (3H, d, J = 6.2 Hz, 3′-Me). The 13C NMR data (Table 2) and DEPT spectrum of 1 indicated the presence of 21 carbon signals, including sixteen aromatic carbons at δC 134.3 (C-1), 125.5 (C-2), 103.5 (C-3), 154.4 (C-4), 155.0 (C-5), 110.0 (C-6), 127.6 (C-7), 114.2 (C-8), 133.3 (C-9), 114.8 (C-10), 106.8 (C-5′), 127.7 (C-6′), 106.5 (C-7′), 155.7 (C-8′), 156.4 (C-9′), and 110.6 (C-10′); one oxygenated methine carbon at δC 66.8 (C-3′); one methoxy carbon at δC 56.1 (4-OMe); one methylene carbon at δC 35.0 (C-2′); one methine carbon at δC 31.3 (C-1′); and one methyl carbon at δC 21.0 (3′-Me). These data suggest that 1 was similar nodulisporin D (4) [20]. The major difference involved the displacement of the methoxy and hydroxyl groups compared with those of 4, which was deduced by the correlations of H-2 and H-3 with C-4 and 4-OMe with C-4, indicating that the methoxy group was attached to C-4 in 1 rather than to C-1 in 4, as shown in the HMBC spectrum (Figure 1). The whole structure of 1 was further confirmed according to the 1H-1H COSY and HMBC spectra. The 1H-1H COSY of 1 allowed for the identification of four fragments, –CH(1′)–CH2(2′)–CH(3′)–CH3, –CH(5′)–CH(6′)–CH(7′)–, –CH(2)–CH(3)–, and –CH(6)–CH(7)–CH(8)–. The HMBC correlations of H-3 with C-1/C-10, H-7 with C-5/C-9, H-8 with C-1, H-5′ with C-7′/C-10′, H-1′ with C-3′, 3′-Me with C-2′/C-3′, and 4-OMe with C-4 confirmed the presence of naphthalene and chroman units (Figure 2). The connection between the chroman and naphthalene moieties within the structure was established by correlations of H-1′ with C-1/C-2 in the HMBC spectrum, further confirming the planar structure of 1.
The relative configurations of C-1′ and C-3′ were deduced from the NOESY correlations between H-1′ and H-2′β, as well as between H-2′β and 3′-Me, combined with the coupling constants of J1′,2′β = 5.8 Hz and J2′β,3′α = 11.6 Hz, indicating the H-1′β and H-3′α configurations (Figure 3). The absolute configuration of 1 was determined as 1′S,3′R according to the quantum chemical ECD calculation (Figure 4) and named as daldinaphchrom A.
Compound 2 was also obtained as a yellow gum, with a molecular formula of C21H20O4 based on HR-ESI-MS data at m/z 359.1258 [M + Na]+, indicating 12 degrees of unsaturation. The 1H NMR data (Table 1), combined with the HSQC spectrum of 2, showed two hydroxyl groups at 4-OH (δH 9.34) and 8′-OH (δH 8.90); eight aromatic protons at δH 7.77 (1H, m, H-8), 7.37 (1H, m, H-7), 6.94 (1H, m, H-6), 6.93 (1H, m, H-6′), 6.90 (1H, m, H-2), 6.62 (1H, d, J = 7.8 Hz, H-3), 6.35 (1H, d, J = 7.4 Hz, H-5′), and 6.25 (1H, d, J = 7.4 Hz, H-7′); one oxygenated methine signal at δH 4.10 (1H, m, H-3′); one methoxyl group at δH 4.02 (3H, s, 5-OMe); one methine proton at δH 4.79 (1H, s, H-1′); one methylene group at δH 2.48 (1H, m, H-2′α) and 1.67 (1H, m, H-2′β); and one methyl group at δH 1.24 (3H, d, J = 6.2 Hz, 3′-Me). Furthermore, the 13C NMR data (Table 2) and DEPT spectrum of 2 indicated the presence of 21 carbon signals, including sixteen aromatic carbons, one oxygenated methine carbon, one methoxy carbon, one methylene carbon, one methine carbon, and one methyl carbon. These 1H and 13C NMR spectroscopic data suggested that the plane structure of 2 was the same as that of nodulisporin D (4) [20]; these results were also confirmed by the COSY and HMBC correlations (Figure 2). The clear difference was the configurations of C-1′ and C-3′. The NOESY correlation of H-1′ and H-3′ indicated that H-1′ and H-3′ exhibited the same configuration in 2 (Figure 3). The absolute configuration of compound 2 was determined to be 1′S,3′S, while that of compound 4 was determined to be 1′S,3′R based on ECD calculations (Figure 4). Thus, the structure of compound 2 was identified as that in Figure 1 and named as daldinaphchrome B.
Compound 3 was also isolated as a yellow gum and had the molecular formula C21H20O4 based on the prominent signal at m/z 359.1259 [M + Na]+ in the HR-ESI-MS spectrum. The 1H and 13C NMR spectroscopic data (Table 1 and Table 2) indicated that the planar structure of 3 was identical to that of nodulisporin E [20]. However, the optical rotation value of nodulisporin E was [α ] D 25 = –4.5 (c = 0.02, CHCl3), and that of compound 3 was [α ] D 25 = +19.5 (c = 0.2, MeOH), indicating the differences in their configurations. The relative configuration of 3 was deduced by NOESY correlations, as was that of nodulisporin E (Figure 3). The absolute configuration of compound 3 was determined to be 1′S,3′R based on quantum chemical ECD calculations (Figure 4). Compound 3 was named daldinaphchrom C.
Compound 5 was obtained as a white powder, with a molecular formula of C15H18O4 based on the HR-ESI-MS data at m/z 285.1098 [M + Na]+, indicating seven degrees of unsaturation. The 1H NMR data (Table 3), combined with the HSQC spectrum of 5 showed three aromatic protons at δH 6.47 (1H, d, J = 8.4 Hz, H-2), 7.34 (1H, t, J = 8.4 Hz, H-3), and 6.36 (1H, d, J = 8.4 Hz, H-4); one oxygenated methine proton at δH 4.13 (2H, m, H-6); two methine protons at δH 1.86 (1H, m, H-8) and 1.85 (1H, br s, H-8a); two methylene groups at δH 2.41 (1H, m, H-5α), 1.39 (1H, m, H-5β), 2.06 (1H, d, J = 12.0 Hz, H-7α), and 1.09 (1H, m, H-7β); and two methyl groups at δH 1.35 (3H, s, H-11) and 0.98 (3H, d, J = 6.2 Hz, H-12). The 13C NMR data (Table 3) contained 15 resonances resulting from two methyl, two methylene, five methine, and six quaternary carbons, including a carbonyl group (δC 201.3, C-9), suggested a chromone skeleton that was further verified by the HMBC correlations. Additionally, there was one oxygenated methine group at δC 66.0 (C-6), two methylene carbon signals at δC 46.1 (C-5) and 42.6 (C-7), one methine group at δC 30.6 (C-8), and two methyl groups at δC 24.4 (C-11) and 19.5 (C-12). Combined with the unsaturation display, this indicates the presence of another ring in the structure. The 1H-1H COSY correlations of H-5α/H-6/H-7β/H-8a/H-12 suggested the presence of a six-membered ring fragment in the structure. The HMBC correlations of H-12 with C-8/C-8a and H-11 with C-5/C-10 indicated the presence of two methyl groups connected at C-8 and C-10, establishing the planar structure of compound 5 (Figure 5). The NOESY correlations of H-6/H-8 and H-6/H-8a, H-11/H-5α and H-5α/H-6, and 12-Me/ H-5β confirmed the relative configurations of 5. The absolute configuration of 5 was determined to be 6R,8S,8aS,10R based on comparing its CD spectrum with that of monodictysin C [25]. The observation of a strong positive cotton effect at 218 nm (+8.93) confirmed that it shared the same absolute configuration as that of the reported structure. The configuration of 5 was also confirmed by the ECD calculations. (Figure 6). Thus, compound 5 was named as daldichrome A (5).
Compound 6 was obtained as a yellow gum, with a molecular formula of C11H14O4 based on HR-ESI-MS data at m/z 233.0780 [M + Na]+, indicating five degrees of unsaturation. The 1H NMR spectroscopic data (Table 3), combined with the HSQC spectrum of 6, showed three aromatic protons at δH 7.17 (1H, dd, J = 8.4, 8.4 Hz, H-7), 6.51 (1H, d, J = 8.4 Hz, H-8), and 6.47 (1H, d, J = 8.4 Hz, H-6); three oxygenated methine protons at δH 4.97 (1H, d, J = 4.2 Hz, H-4), 4.06 (1H, dq, J = 9.6, 6.0 Hz, H-2), and 3.61 (1H, br s, H-3); one methyl group at δH 1.49 (3H, d, J = 6.0 Hz, 2-Me); and one methoxy group at δH 3.88 (3H, s, 5-OMe). In addition, 11 carbon signals were detected in the 13C NMR spectrum, including six aromatic carbons at δC 158.9, 155.2, 130.3, 112.2, 109.9, and 102.4; three oxygenated methine carbons at 71.2, 71.1, and 61.5; one methoxy group at 55.8 (5-OMe); and one methyl group at 17.6 (2-Me). The 1H-1H COSY correlations of H-6/H-7/H-8 and 2-Me/H-2/H-3/H-4 suggested two fragments. Combining the HMBC correlations of H-7/C-5 and C-8a, H-5/5-OMe established the planar structure of compound 6 (Figure 7). The large coupling constant (J2,3 = 9.6 Hz) and the small coupling constant (J3,4 = 4.2 Hz) in the 1H NMR spectrum indicate the trans configuration of H-2 and H-3, and the cis configuration of the vicinal diol of H-3 and H-4. The absolute configuration of compound 6 was determined to be 2S,3R,4R based on quantum chemical ECD calculations (Figure 8), and it was named as daldichrome B (6).
The other compounds were identified as 8-ethyl-7-hydroxy-2,3-dimethyl-4-oxo-chromene-5-carboxylic acid (7), (2S)-2,3-dihydro-5,6-dihydroxy-2-methyl-4H-1-benzopyran-4-one (8), 8-methoxynaphthalene-1,7-diol (9), and 1-(2,6-dihydroxy-phenyl)butan-1-one (10). The 1H and 13C NMR data of the known compounds 4, 710 are in Supplementary Materials.

2.2. Bioactivity Assay

Compounds 14 were evaluated for their inhibitory activities against LPS-induced nitric oxide (NO) production in RAW 264.7 mouse macrophages, with compounds 24 exhibiting >50% inhibition at a concentration of 100 μM. Only compound 1 demonstrated moderate inhibition of NO accumulation induced by LPS on RAW 264.7 cells in a dose-dependent manner at concentrations of 25, 50, and 60 μM. Compound 1 exhibited anti-inflammatory activity with an IC50 value of 62.9 µM, better than that of the positive control dexamethasone, with an IC50 value of 136.8 µM. Additionally, compound 1 significantly inhibited IL-6 production in vitro, surpassing the inhibitory activity of dexamethasone (Figure 9). Compound 1 did not show toxicity at concentrations of 25, 50, and 60 µM (Figure 10).
The inhibitory effects of inflammation-related iNOS and COX-2 for 1 were also measured using western blotting. As a result, the protein expression of iNOS was apparently down-regulated after the treatment of 1 with different concentrations (60.0, 50.0, and 25.0 µM) in a dose-dependent manner. Compound 1 exhibited no significant effect on the expression of the COX-2 protein (Figure 11).
In order to study the possible recognition between the iNOS protein and compound 1, AutoDock Vina was applied, as depicted in Figure 12 [26]; 1 exhibited an optimal fit within the binding pocket of iNOS protein, which was delineated by the side chains of five amino acid residues, Arg 687, Val 686, Val 537, Arg 536, and Phe 684, which may be critical for the observed inhibitory activity.
Compounds 7 and 8 exhibited DPPH radical scavenging activity, with IC50 values of 117.4 µM and 46.2 µM, respectively. Compound 8 demonstrated activity compared with the positive control, ascorbic acid, which had an IC50 value of 45.6 µM. Compounds 4 and 10 showed ABTS+ radical scavenging activity, with IC50 values of 66.6 µM and 33.2 µM, respectively. Notably, compound 10 demonstrated better efficacy than the positive control (vitamin C, IC50 = 59.7 µM).
Compounds 13, 7, and 9 showed weak antibacterial activity against Staphylococcus aureus (ATCC 29213) and two Methicillin-resistant S. aureus (MRSA) (ATCC 700699 and 43300), with MIC values of 74.4–390.6 μM, while the positive control vanconmycin exhibited an IC50 value of 1.0 µM (Table 4).

3. Materials and Methods

3.1. General Experimental Procedures

A Modular Circular Polarimeter 500 (Anton Paar, Graz, Austria) was used to detect optical rotation. A JASCO J-715 spectrophotometer (JASCO, Tokyo, Japan) was used to measure ECD spectra. The 1D (1H and 13C) and 2D (HSQC, HMBC, COSY, and NOESY) NMR spectra were measured on an NMR spectrometer (JEOL, 600 MHz, Tokyo, Japan) and a Bruker AV-400 (Bruker Corporation, Zurich, Switzerland) instrument with TMS as the internal standard. Chemical shifts (δ, ppm) were referenced using the residual solvent signals of DMSO-d6 (δH 2.50; δC 39.5), CD3OD-d4 (δH 3.31; δC 49.0), and CDCl3 (δH 7.26; δC 77.2). ESI-MS and HR-ESI-MS spectra were obtained on a Bruker Daltonics Apex-Ultra 7.0 T (Bruker Corporation, Billerica, MA, USA) and a Q-TOF Ultima Global GAA076 LC mass spectrometer. For semipreparative HPLC, an Agilent 1100 prep-HPLC system with a Waters C18 semipreparative column (9.4 × 250 mm, 7 μm) was used. Sephadex LH-20 (Pharmacia Co. Ltd., Sandwich, UK) and silica gel (200–300 and 300–400 mesh, Qingdao Marine Chemical Factory, Qingdao, China) were used for column chromatography (CC). Silica gel (GF254) for TLC were supplied by the Qingdao Marine Chemical Factory in China. All solvents used were of analytical grade (Guangzhou, China).

3.2. Fungal Material

The fungal strain HJX1P2 was collected from the Hainan Mangrove Conservation Area, Haikou. It was stored in the Key Laboratory of Tropical Medicinal Resource Chemistry of the Ministry of Education, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou, China. The strain was designated Daldinia eschscholzii HJX1P2 based on BLAST analysis of the ITS sequence (Supporting Information). Finally, the sequence was deposited in GenBank with the accession number OQ683818.

3.3. Fermentation and Extraction

The fungal strain Daldinia eschscholzii HJX1P2 was statically cultivated in potato dextrose broth PDB medium (26.0 g/1 L H2O, Potato extract 6.0 g, Glucose 20.0 g), followed by culture in 200 mL of PDB medium (0.3% sea salt) in 1 L Erlenmeyer flasks at 28 °C for 3 days on a rotary shaker at 180 rpm. A large-scale fermentation was then conducted at 26 °C for 28 days using a rice medium (50 g rice, 0.3% sea salt, and 50 mL H2O) in 1 L flasks (200 flasks total) under static conditions. The entire fermented culture was extracted with ethyl acetate three times, yielding a brown extract weighing 60.0 g.

3.4. Isolation and Purification

The extract was evaporated to dryness under a vacuum to obtain the organic extract (60.0 g), which was separated in twelve fractions (Fr.1−Fr.12) by silica gel column chromatography (CC) eluting with a petroleum ether (PE)/EtOAc gradient system from 0:1 to 1:0. Fraction Fr.1 was analyzed using TLC and 1H NMR to reveal mainly fatty acids. Fraction Fr.2 (4.1 g) was subjected to CC over octadecylsilyl (ODS) eluting with a MeOH/H2O gradient (30–100%) to yield six subfractions (SFr.2-1–SFr.2-6). Subfraction SFr.2-4 (0.85 g) was separated by CC on Sephadex LH-20 eluting with PE/CHCl3/MeOH (2:1:1, v/v/v) to yield three subfractions (SFr.2-4-1 to SFr.2-4-3), and then further purified by semipreparative HPLC (MeOH/H2O, 65:35, 2 mL/min) to give 1 (13.5 mg, tR = 37.1 min), 4 (14.1 mg, tR = 32.3 min), and 8 (4.4 mg, tR = 15.5 min). Subfraction SFr.2-5 (0.17 g) was purified by semipreparative HPLC (MeOH/H2O, 70:30, 2 mL/min) to give 9 (6.5 mg, tR = 25.3 min). Fraction Fr.4 (3.9 g) was subjected to CC over ODS eluting with a MeOH/H2O gradient (30–100%) to yield four subfractions (SFr.4-1−SFr.4-4). Subfraction SFr.4-2 (0.56 g) was separated by CC on Sephadex LH-20 eluting with PE/CHCl3/MeOH (2:1:1, v/v/v) to yield four subfractions (SFr.4-2-1 to SFr.4-2-4), and then further purified by semipreparative HPLC (MeOH/H2O, 65:35, 2 mL/min) to give 2 (8.4 mg, tR = 27.5 min), 3 (10.5 mg, tR = 33.5 min), 7 (2.3 mg, tR = 35.8 min), and 10 (2.9 mg, tR = 15.0 min). Fraction Fr.7 (1.9 g) was subjected by silica gel CC with a PE/EtOAc gradient system from 0:1 to 1:0 to yield seven subfractions (SFr.7-1 to SFr.7-7). Subfraction SFr.7-7 (0.60 g) was separated on Sephadex LH-20 eluting with PE/CHCl3/MeOH (2:1:1, v/v/v) to yield three subfractions (SFr.7-7-1 to SFr.7-7-3), and then further purified by semipreparative HPLC (MeOH/H2O, 30:70, 2 mL/min) to give 5 (1.5 mg, tR = 14.5 min) and 6 (1.4 mg, tR = 20.9 min). The HPLC detection wavelengths were 254, 210, 230, and 280 nm.

3.5. Spectroscopic Data of Compounds

Daldinaphchrome A (1): yellow oil; [α ] D 25 −161.0 (c 0.2, CH3OH); UV (MeOH) λmax (log ε) = 201, 203, and 213; IR (KBr) νmax 3447, 1594, 1352, 1020, and 518 cm−1; ECD (2.98 mM, MeOH) λmax (∆ε) 198 (+17.51), 213 (−4.94), and 224 (+2.12); 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS m/z 335.1291 [M-H] (calcd for C21H20O4Na+, 335.1289).
Daldinaphchrome B (2): brown oil; [α ] D 25 +18.0 (c 0.2, CH3OH); UV (MeOH) λmax (log ε) 214, 257, and 331; IR (KBr) νmax 3462, 1596, 1353, and 527 cm−1; ECD (2.98 mM, MeOH) λmax (∆ε) 200 (+28.40), 207 (−9.56), 219 (+15.86), and 234 (−11.06); 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS m/z 359.1258 [M + Na]+ (calcd for C21H20O4 Na +, 359.1254).
Daldinaphchrome C (3): yellow oil; [α ] D 25 +19.5 (c 0.2, CH3OH); UV (MeOH) λmax (log ε) 211, 257, and 327; IR (KBr) νmax 3450, 2829, 1596, 1354, and 517 cm−1; ECD (2.98 mM, MeOH) λmax (∆ε) 239 (+10.95), 251 (−12.68), and 268 (+33.07); 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS m/z 359.1254 [M + Na]+ (calcd for C21H20O4Na+, 359.1259).
Daldichrome A (5): colorless oil; [α ] D 25 +161.0 (c 0.1, CH3OH); UV (MeOH) λmax (log ε) 199, 219, 248, and 278; IR (KBr) νmax 3454, 2830, 1597, 1356, and 518 cm−1; ECD (3.82 mM, MeOH) λmax (∆ε) 190 (−40.32), 216 (+22.35), and 241 (+3.80); 1H and 13C NMR data, see Table 3; HRESIMS m/z 285.1098 [M + Na]+ (calcd for C15H18O4Na+, 285.1097).
Daldichrome B (6): yellow solid; [α ] D 25 +32.0 (c 0.1, CH3OH); UV (MeOH) λmax (log ε) 200, 215, 253, and 278; IR (KBr) νmax 3455, 11595, 1353, and 517 cm−1; ECD (4.76 mM, MeOH) λmax (∆ε) 205 (+14.04), 211 (−5.66), 217 (+16.80), and 222 (−7.25); 1H and 13C NMR data see Table 3; HRESIMS m/z 233.0780 [M + Na]+ (calcd for C11H14O4Na+, 233.0784).

3.6. ECD Computation Section

Geometries were optimized at the level of B3LYP/6-31G(d) using density functional theory (DFT) calculations. The optimized geometries to be minima (no imaginary frequency) or transition states (TSs, having unique one imaginary frequency) were verified by harmonic frequency analysis. The ECD calculations for the stable conformers were carried out at the B3LYP/6-31G(d) level in the gas phase using Gaussian 09 software [27]. Boltzmann statistics were used to combine ECD spectra using SpecDis 1.64 software [28].

3.7. Biological Assay Protocols

3.7.1. Anti-Inflammation Activity Assay

The murine RAW 264.7 macrophage cells (Shanghai Cell Bank of the Chinese Academy of Sciences, Shanghai, China) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) heatinactivated fetal bovine serum (FBS) and 1% penicillin–streptomycin (100 U/mL, Gibco) at 37 °C and maintained in 5% CO2 humidified air. RAW 264.7 cells (1 × 106 cells/well) were cultured in six-well plates with serum-free DMEM for 12 h and then pretreated with compound 1 (25, 50, and 60 μM) for 2 h prior to stimulation with LPS (1 μg/mL) for 18 h. The supernatant was harvested, and the concentrations of TNF-α, IL-1β, and IL-6 in the culture medium were determined using commercial ELISA kits according to the instructions.

3.7.2. Antioxidant Activity Assay

The obtained compounds were evaluated for their antioxidant activities against DPPH and ABTS+ [24,29]. The effect of the compounds on DPPH radicals were estimated as previously reported. In summary, a methanolic DPPH solution was supplemented with compounds to achieve final concentrations of 6.25–100 µg/mL. The mixture was shaken and allowed to stand for 20 min at room temperature in the dark, after which the OD517 values were measured using a microplate reader (SYNERGY H1 BioTek). The scavenging rate (K%) was calculated as follows: K = (A blank group − A)/A blank group × 100%. Vitamin C served as the positive control. The free radical scavenging rate (K%) was calculated from the OD517 values, and EC50 was determined using IBM SPSS Statistics 25.
The stored solution of ABTS was diluted with 95% ethanol to ABST+ solution with an absorbance of 0.70 ± 0.02 at 734 nm. Then, the mixture containing 10 μL of sample solution and 190 μL of ABTS+ solution was cultured for 6 min at 25 °C in the dark. The mixture was shaken and allowed to stand for 7 min at room temperature in the dark, after which the OD734 values were measured using a microplate reader (SYNERGY H1 BioTek). The scavenging rate (SR%) was calculated as follows: SR = (A blank group − A)/A blank group × 100%. Vitamin C served as the positive control. The scavenging rate (SR%) was calculated from the OD734 values, and EC50 was determined using IBM SPSS statistics 25.

3.7.3. Antibacterial Activity Assay

The antibacterial activities against three bacteria Staphylococcus aureus (ATCC700699, ATCC43300, ATCC29213) were evaluated in 96-well plates with a twofold serial dilution method described previously [30]. The minimum inhibitory concentration (MIC) values are shown in Table 4. The incubation conditions were as follows: fungi PDB medium (potato extract 0.4% and glucose 2%), 26 °C, 48 h; bacteria LB medium (yeast extract 0.5%, tryptone 1%, and NaCl 0.5%), 26 °C, 48 h.

3.8. Molecular Docking Studies

Molecular docking simulations were performed as previously described [31].

3.9. Statistical Analysis

The data obtained are presented as the means ± SD of three independent experiments. A one-way analysis of variance (ANOVA) test was used for statistical analysis. GraphPad Prism 5.02 (GraphPad Software Inc., San Diego, CA, USA) was used to perform the analyses.

4. Conclusions

In conclusion, five new metabolites, including three new naphthalene–chroman dimer derivatives (13) and two new chroman derivatives (5 and 6), together with five known ones (4, 710), were isolated from the mangrove-sediment-derived fungus Daldinia eschscholzii HJX1P2. Their structures were determined by extensive spectroscopic analyses and ECD calculations. Compound 1 exhibited significant inhibitory effects on NO secretion in LPS-activated RAW 264.7 macrophage cells, with an IC50 value of 62.9 μM, and effectively suppressed the expression of IL-6 in LPS-induced RAW 264.7 cells. Compounds 7 and 8 showed DPPH radical scavenging activity, with IC50 values of 117.4 and 46.2 µM, respectively. Compounds 4 and 10 showed ABTS+ radical scavenging activity, with IC50 values of 66.6 and 33.2 µM, respectively. In addition, compounds 13, 7, and 9 showed weak antibacterial activity against S. aureus and two MRSA strains, with MIC values ranging from 74.4 to 390.6 μM. These results indicated that these naphthalene–chroman dimer derivatives could serve as promising lead molecules for the development of anti-inflammatory and antibacterial drugs.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/md23060238/s1, Figure S1. The 1H NMR spectrum of 1 in DMSO-d6; Figure S2. The 13C NMR spectrum of 1 in DMSO-d6; Figure S3. The DEPT-135 spectrum of 1 in DMSO-d6; Figure S4. The HSQC spectrum of 1 in DMSO-d6; Figure S5. The 1H-1H COSY spectrum of 1 in DMSO-d6; Figure S6. The HMBC spectrum of 1 in DMSO-d6; Figure S7. The NOESY spectrum of 1 in DMSO-d6; Figure S8. The HR-ESI-MS spectrum of 1; Figure S9. The 1H NMR spectrum of 2 in DMSO-d6; Figure S10. The 13C NMR spectrum of 2 in DMSO-d6; Figure S11. The DEPT-135 spectrum of 2 in DMSO-d6; Figure S12. The HSQC spectrum of 2 in DMSO-d6; Figure S13. The 1H-1H COSY spectrum of 2 in DMSO-d6; Figure S14. The HMBC spectrum of 2 in DMSO-d6; Figure S15. The NOESY spectrum of 2 in DMSO-d6; Figure S16. The HR-ESI-MS spectrum of 2; Figure S17. The 1H NMR spectrum of 3 in DMSO-d6; Figure S18. The 13C NMR spectrum of 3 in DMSO-d6; Figure S19. The DEPT-135 spectrum of 3 in DMSO-d6; Figure S20. The HSQC spectrum of 3 in DMSO-d6; Figure S21. The 1H-1H COSY spectrum of 3 in DMSO-d6; Figure S22. The HMBC spectrum of 3 in DMSO-d6; Figure S23. The NOESY spectrum of 3 in DMSO-d6; Figure S24. The HR-ESI-MS spectrum of 3; Figure S25. The 1H NMR spectrum of 5 in CDCl3; Figure S26. The 13C NMR spectrum of 5 in CDCl3; Figure S27. The DEPT-135 spectrum of 5 in CDCl3; Figure S28. The HSQC spectrum of 5 in CDCl3; Figure S29. The 1H-1H COSY spectrum of 5 in CDCl3; Figure S30. The HMBC spectrum of 5 in CDCl3; Figure S31. The NOESY spectrum of 5 in CDCl3; Figure S32. The HR-ESI-MS spectrum of 5; Figure S33. The 1H NMR spectrum of 6 in CDCl3; Figure S34. The 13C NMR spectrum of 6 in CDCl3; Figure S35. The DEPT-135 spectrum of 6 in CDCl3; Figure S36. The HSQC spectrum of 6 in CDCl3; Figure S37. The 1H-1H COSY spectrum of 6 in CDCl3; Figure S38. The HMBC spectrum of 6 in CDCl3; Figure S39. The NOESY spectrum of 6 in CDCl3; Figure S40. The HR-ESI-MS spectrum of 6; Figure S41. The 1H NMR spectrum of 2 in CD3OD-d4; Figure S42. The 13C NMR spectrum of 2 in CD3OD-d4; Figure S43. The DEPT-135 spectrum of 2 in CD3OD-d4; Figure S44. The HSQC spectrum of 2 in CD3OD-d4; Figure S45. The UV spectrum of 1; Figure S46. The UV spectrum of 2; Figure S47. The UV spectrum of 3; Figure S48. The UV spectrum of 5; Figure S49. The UV spectrum of 6; Figure S50. The IR spectrum of 1; Figure S51. The IR spectrum of 2; Figure S52. The IR spectrum of 3; Figure S53. The IR spectrum of 5; Figure S54. The IR spectrum of 6; Figure S55. The 1H NMR spectrum of 4 in DMSO-d6; Figure S56. The 13C NMR spectrum of 4 in DMSO-d6; Figure S57. The 1H NMR spectrum of 7 in DMSO-d6; Figure S58. The 13C NMR spectrum of 7 in DMSO-d6; Figure S59. The 1H NMR spectrum of 8 in CDCl3; Figure S60. The 13C NMR spectrum of 8 in CDCl3; Figure S61. The 1H NMR spectrum of 9 in CD3OD; Figure S62. The 13C NMR spectrum of 9 in CD3OD; Figure S63. The 1H NMR spectrum of 10 in CDCl3; Figure S64. The 13C NMR spectrum of 10 in CDCl3.

Author Contributions

C.Z. and G.H. conceived and revised this article; M.Y. prepared and wrote the original draft; Y.Q. and S.C. performed bioactivity evaluation; J.S. and X.G. conducted the literature analysis; J.F., F.L., W.Z., and W.K. reviewed and edited this article. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (Nos. 32160108 and 2217702), the Key Research and Development Program of Hainan Province (No. ZDYF2024SHFZ116), the Team Innovation Center for Academicians of Hainan Province, the Specific Research Fund for the Innovation Center of Hainan Province Academicians (No. YSPTZX202309), and the Innovation Experiment Project for College Students (No. hsyx2022-1).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data for the research results can be obtained from supporting information.

Conflicts of Interest

The authors declare no competing financial interests.

References

  1. Lin, X.B.; Gao, D.Z.; Zheng, P.F.; Sun, D.Y.; Hu, W.F.; Tian, D.F.; Du, W. The effects of mangrove growth on sediment nitrogen mineralization and immobilization are more intense on sandy coasts compared to muddy coasts. Catena 2024, 243, 108172. [Google Scholar] [CrossRef]
  2. Nagahawatta, D.P.; Liyanage, N.M.; Thilina, U.J.; Jayawardhana, H.H.A.C.K.; Jeong, S.H.; Kwon, H.J.; Jeon, Y.J. Role of marine natural products in the development of antiviral agents against SARS-CoV-2: Potential and prospects. Mar. Life Sci. Technol. 2024, 6, 280–297. [Google Scholar] [CrossRef] [PubMed]
  3. Zou, G.; Yang, W.C.; Chen, T.; Liu, Z.M.; Chen, Y.; Li, T.B.; Said, G.; Sun, B.; Wang, B.; She, Z.G. Griseofulvin enantiomers and bromine-containing griseofulvin derivatives with antifungal activity produced by the mangrove endophytic fungus Nigrospora sp. QQYB1. Mar. Life Sci. Technol. 2024, 6, 102–114. [Google Scholar] [CrossRef]
  4. Lv, H.W.; Su, H.B.; Xue, Y.X.; Jia, J.; Bi, H.K.; Wang, S.B.; Zhang, J.K.; Zhu, M.D.; Emam, M.; Wang, H.; et al. Polyketides with potential bioactivities from the mangrove-derived fungus Talaromyces sp. WHUF0362. Mar. Life Sci. Technol. 2023, 5, 232–241. [Google Scholar] [CrossRef] [PubMed]
  5. Shi, J.; Yu, M.; Chen, W.; Chen, S.; Qiu, Y.; Xu, Z.; Wang, Y.; Huang, G.; Zheng, C. Recent discovery of nitrogen heterocycles from marine-derived Aspergillus species. Mar. Drugs 2024, 22, 321. [Google Scholar] [CrossRef]
  6. Qiu, Y.; Chen, S.; Yu, M.; Shi, J.; Liu, J.; Li, X.; Chen, J.; Sun, X.; Huang, G.; Zheng, C. Natural products from marine-derived fungi with anti-inflammatory activity. Mar. Drugs 2024, 22, 433. [Google Scholar] [CrossRef]
  7. Yu, M.; Chen, S.J.; Shi, J.Y.; Chen, W.K.; Qiu, Y.K.; Lan, J.; Qu, S.Y.; Feng, J.Y.; Wang, R.; Lin, F.R.; et al. Structures and biological activities of secondary metabolites from Daldinia spp. J. Fungi 2024, 10, 833. [Google Scholar] [CrossRef]
  8. Buchanan, M.S.; Hashimoto, T.; Asakawa, Y. Five 10-phenyl-[11]-cytochalasans from a Dalinia fungal species. Phytochemistry 1995, 40, 135–140. [Google Scholar] [CrossRef]
  9. Chen, J.X.; Yang, X.Q.; Wang, X.Y.; Han, H.L.; Cai, Z.J.; Xu, H.; Yang, Y.B.; Ding, Z.T. Antifeedant, antifungal cryptic polyketides with six structural frameworks from tea endophyte Daldinia eschscholtzii propelled by the antagonistic coculture with phytopathogen Colletotrichum pseudomajus and different culture methods. J. Agric. Food Chem. 2024, 72, 378–389. [Google Scholar] [CrossRef]
  10. Lee, S.; Park, I.G.; Choi, J.W.; Son, J.Y.; Lee, J.W.; Hur, J.S.; Kim, Y.; Nam, S.J.; Kang, H.S.; Deyrup, S.T.; et al. Daldipyrenones A-C: Caged [6,6,6,6,6] polyketides derived from an endolichenic fungus Daldinia pyrenaica 047188. Org. Lett. 2023, 25, 6725–6729. [Google Scholar] [CrossRef]
  11. Xu, Z.Y.; Feng, T.; Wen, Z.C.; Li, Q.; Chen, B.T.; Liu, P.H.; Xu, J. New naphthalene derivatives from the mangrove endophytic fungus Daldinia eschscholzii MCZ-18. Mar. Drugs 2024, 22, 242. [Google Scholar] [CrossRef]
  12. Zhang, Y.L.; Ge, H.M.; Zhao, W.; Dong, H.; Xu, Q.; Li, S.H.; Li, J.; Zhang, J.; Song, Y.C.; Tan, R.X. Unprecedented immunosuppressive polyketides from Daldinia eschscholzii, a mantis-associated fungus. Angew. Chem. Int. Ed. 2008, 47, 5823–5826. [Google Scholar] [CrossRef]
  13. Gong, D.W.; Xie, B.P.; Sun, Y.J.; Cheng, Y.Y.; Tian, X.F.; Zhou, Z.Z.; Tian, L.W. Daldiconoids A-G: 3,4-secolanostane triterpenoids from the fruiting bodies of Daldinia concentrica and their anti-inflammatory activity. Phytochemistry 2024, 225, 114201. [Google Scholar] [CrossRef] [PubMed]
  14. Liao, H.X.; Zheng, C.J.; Huang, G.L.; Mei, R.Q.; Nong, X.H.; Shao, T.M.; Chen, G.Y.; Wang, C.Y. Bioactive polyketide derivatives from the mangrove-derived fungus Daldinia eschscholtzii HJ004. J. Nat. Prod. 2019, 82, 2211–2219. [Google Scholar] [CrossRef] [PubMed]
  15. Bai, M.; Zheng, C.J.; Nong, X.H.; Zhou, X.M.; Luo, Y.P.; Chen, G.Y. Four new insecticidal xanthene derivatives from the mangrove-derived fungus Penicillium sp. JY246. Mar. Drugs 2019, 17, 649. [Google Scholar] [CrossRef] [PubMed]
  16. Bai, M.; Huang, G.L.; Mei, R.Q.; Wang, B.; Luo, Y.P.; Nong, X.H.; Chen, G.Y.; Zheng, C.J. Bioactive lactones from the mangrove-derived fungus Penicillium sp. TGM112. Mar. Drugs 2019, 17, 433. [Google Scholar] [CrossRef]
  17. Bai, M.; Zheng, C.J.; Chen, G.Y. Austins-type meroterpenoids from a mangrove-derived Penicillium sp. J. Nat. Prod. 2021, 84, 2104–2110. [Google Scholar] [CrossRef]
  18. Bai, M.; Zheng, C.J.; Huang, G.L.; Mei, R.Q.; Wang, B.; Luo, Y.P.; Zheng, C.; Niu, Z.G.; Chen, G.Y. Bioactive meroterpenoids and isocoumarins from the mangrove-derived fungus Penicillium sp. TGM112. J. Nat. Prod. 2019, 82, 1155–1164. [Google Scholar] [CrossRef]
  19. Wang, Y.; Chen, W.H.; Xu, Z.F.; Bai, Q.Q.; Zhou, X.M.; Zheng, C.J.; Bai, M.; Chen, G.Y. Biological secondary metabolites from the Lumnitzera littorea-derived fungus Penicillium oxalicum HLLG-13. Mar. Drugs 2023, 21, 22. [Google Scholar] [CrossRef]
  20. Dai, J.Q.; Krohn, K.; Draeger, S.; Schulz, B. New naphthalene-chroman coupling products from the endophytic fungus, Nodulisporium sp. from Erica arborea. Eur. J. Org. Chem. 2009, 2009, 1564–1569. [Google Scholar] [CrossRef]
  21. Hainan Normal University. Preparation of Chromogen Ketone Crystal Form in Rhizophora Apiculata-Derived Fungi And Its Application Assignee. CN115724816 A, 3 March 2023. (In Chinese). [Google Scholar]
  22. Luo, Y.P.; Zheng, C.J.; Chen, G.Y.; Song, X.P.; Wang, Z. Three new polyketides from a mangrove-derived fungus Colletotrichum gloeosporioides. J. Antibiot. 2019, 72, 513–517. [Google Scholar] [CrossRef] [PubMed]
  23. Chang, C.W.; Chang, H.S.; Cheng, M.J.; Liu, T.W.; Hsieh, S.Y.; Yuan, G.F.; Chen, I.S. Inhibitory effects of constituents of an endophytic fungus Hypoxylon investiens on nitric oxide and interleukin-6 production in RAW 264.7 Macrophages. Chem. Biodivers. 2014, 11, 949–961. [Google Scholar] [CrossRef] [PubMed]
  24. Lu, S.M.; Liao, C.J.; Xu, Y.; Gui, T.Y.; Sui, H.L.; Zhou, M. Two new ketene derivatives from the endophytic fungus Daldinia eschscholtzii J11. Phytochem. Lett. 2023, 58, 81–85. [Google Scholar] [CrossRef]
  25. Krick, A.; Kehraus, S.; Gerhauser, C.; Klimo, K.; Nieger, M.; Maier, A.; Fiebig, H.H.; Atodiresei, I.; Raabe, G.; Fleischhauer, J.; et al. Potential cancer chemopreventive in vitro activities of monomeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis. J. Nat. Prod. 2007, 70, 353–360. [Google Scholar] [CrossRef] [PubMed]
  26. Jin, J.; Li, Y.L.; Chen, L.H.; Zhang, F.; Zuo, X.Y.; Zeng, Y.R.; Yang, J.; Hao, X.J.; Yuan, C.M. Six pairs of α-pyrone meroterpenoid dimers from Hypericum monogynum with antineuroinflammatory activity. Org. Chem. Front. 2025, 12, 1593. [Google Scholar] [CrossRef]
  27. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A. Gaussian 09; Gaussian Inc.: Wallingford, UK, 2009. [Google Scholar]
  28. Bruhn, T.; Schaumloffel, A.; Hemberger, Y.; Bringmann, G. SpecDis: Quantifying the comparison of calculated and experimental electronic circular dichroism spectra. Chirality 2013, 25, 243–249. [Google Scholar] [CrossRef]
  29. Chen, Y.; Cai, J.; Xia, Z.; Chen, C.; Liu, Y.; Jayasinghe, L.; Wang, X.; Zhou, X. New Bioactive polyketides from the mangrove-derived fungus Penicillium sp. SCSIO 41411. Mar. Drugs 2024, 22, 384. [Google Scholar] [CrossRef]
  30. Ke, L.M.; Zhang, Z.R.; Li, S.W.; Zeng, Y.B.; Su, M.Z.; Guo, Y.W. Bioactive steroids with structural diversity from the south china sea soft coral Lobophytum sp. and sponge Xestospongia sp. Mar. Drugs 2025, 23, 36. [Google Scholar] [CrossRef]
  31. Liang, Y.; An, L.; Shi, Z.; Zhang, X.; Xie, C.; Tuerhong, M.; Song, Z.; Ohizumi, Y.; Lee, D.; Shuai, L.; et al. Bioactive diterpenoids from the stems of Euphorbia antiquorum. J. Nat. Prod. 2019, 82, 1634–1644. [Google Scholar] [CrossRef]
Figure 1. Structures of compounds 110.
Figure 1. Structures of compounds 110.
Marinedrugs 23 00238 g001
Figure 2. Key HMBC and 1H-1H COSY correlations of compounds 13.
Figure 2. Key HMBC and 1H-1H COSY correlations of compounds 13.
Marinedrugs 23 00238 g002
Figure 3. Key NOESY correlations of compounds 13.
Figure 3. Key NOESY correlations of compounds 13.
Marinedrugs 23 00238 g003
Figure 4. Experimental and calculated ECD spectra of compounds 14. The green line corresponds to the optimal fitting configuration of compounds 13. The relative configuration of compound 4 had been determined in the literature; therefore, only two configurations were computed, with the red line corresponding to the optimal fitting configuration.
Figure 4. Experimental and calculated ECD spectra of compounds 14. The green line corresponds to the optimal fitting configuration of compounds 13. The relative configuration of compound 4 had been determined in the literature; therefore, only two configurations were computed, with the red line corresponding to the optimal fitting configuration.
Marinedrugs 23 00238 g004
Figure 5. Key HMBC, 1H-1H COSY, and NOESY correlations of compound 5.
Figure 5. Key HMBC, 1H-1H COSY, and NOESY correlations of compound 5.
Marinedrugs 23 00238 g005
Figure 6. Experimental and calculated ECD spectra of compound 5 and CD spectrum of monodictysin C.
Figure 6. Experimental and calculated ECD spectra of compound 5 and CD spectrum of monodictysin C.
Marinedrugs 23 00238 g006
Figure 7. Key HMBC and 1H-1H COSY correlations of compound 6.
Figure 7. Key HMBC and 1H-1H COSY correlations of compound 6.
Marinedrugs 23 00238 g007
Figure 8. Experimental and calculated ECD spectra of compound 6.
Figure 8. Experimental and calculated ECD spectra of compound 6.
Marinedrugs 23 00238 g008
Figure 9. The expression levels of IL-1β, IL-6, and TNF-α of compound 1. Data rendered are the mean ± SD, n = 3. In comparison with the control, *** p < 0.001. Con: Control, Dexa: Dexamethasone.
Figure 9. The expression levels of IL-1β, IL-6, and TNF-α of compound 1. Data rendered are the mean ± SD, n = 3. In comparison with the control, *** p < 0.001. Con: Control, Dexa: Dexamethasone.
Marinedrugs 23 00238 g009
Figure 10. Influences of compound 1 on NO production for LPS-induced RAW 264.7 cells and cell viability. Data rendered are the mean ± SD, n = 3. In comparison to the control, *** p < 0.001. Con: Control, Dexa: Dexamethasone.
Figure 10. Influences of compound 1 on NO production for LPS-induced RAW 264.7 cells and cell viability. Data rendered are the mean ± SD, n = 3. In comparison to the control, *** p < 0.001. Con: Control, Dexa: Dexamethasone.
Marinedrugs 23 00238 g010
Figure 11. Influences of compound 1 on iNOS, COX-2, and β-actin protein expression were detected using western blotting. Data rendered are the mean ± SD, n = 3. In comparison with the control, *** p < 0.001. Con: Control, Dexa: Dexamethasone.
Figure 11. Influences of compound 1 on iNOS, COX-2, and β-actin protein expression were detected using western blotting. Data rendered are the mean ± SD, n = 3. In comparison with the control, *** p < 0.001. Con: Control, Dexa: Dexamethasone.
Marinedrugs 23 00238 g011
Figure 12. Binding positions between 1 and iNOS protein.
Figure 12. Binding positions between 1 and iNOS protein.
Marinedrugs 23 00238 g012
Table 1. 1H NMR spectroscopic data of compounds 14 in DMSO-d6.
Table 1. 1H NMR spectroscopic data of compounds 14 in DMSO-d6.
Position1234
δH (J in Hz)δH (J in Hz)δH (J in Hz)δH (J in Hz)
1--7.15, d (8.4)-
26.60 d (8.0)6.90, m6.70, d (8.4)6.58, d (8.0)
36.80 d (8.0)6.62, d (7.8)-6.62, d (8.0)
4----
5----
66.84 d (7.8)6.94, m6.94, d (7.2)7.03, d (8.0)
77.45 t (7.8)7.37, s7.30, t (7.2)7.49, t (8.0)
87.70 d (7.8)7.77, s7.34, d (7.8)7.84, d (8.8)
9----
10----
1′4.80, d (5.6)4.79, s4.61, d (4.8)4.81, d (5.2)
2′α, 1.86, d (13.6), β, 1.95. ddd (13.6, 11.6, 5.6)α, 1.67, m,
β, 2.48, m
α, 1.81, dt (13.6, 5.8), β, 2.06, d (13.6)α, 1.84, m
β, 1.94, m
3′3.87, m4.10, m3.87, ddq (1.6, 6.0, 12.4)3.85, m
5′6.35, d (8.4)6.35, d (7.4)6.34, d (7.8)6.35, d (8.0)
6′6.97, t (8.4) 6.93, m6.97, d (8.4)6.97, t (8.0)
7′6.35, d (8.4)6.25, d (7.4)6.33, d (7.8)6.35, d (8.0)
8′----
9′----
10′----
3′-Me1.18, d (6.2)1.24, d (6.2)1.21, d (6.6)1.17, d (6.0)
8′-OH9.62, s8.90, s9.18, s9.16, s
4/5-OH9.36, s9.34, s9.82, s9.41, s
4/5-OMe3.96, s4.02, s4.06, s4.04, s
Table 2. 13C NMR spectroscopic data of compounds 14 in DMSO-d6.
Table 2. 13C NMR spectroscopic data of compounds 14 in DMSO-d6.
Position1234
δC, TypeδC, TypeδC, TypeδC, Type
1134.3, C127.1, C117.7, CH131.7, C
2125.5, CH127.1, CH (overlapped)127.6, CH127.0, CH
3103.5, CH110.1, CH126.4, C109.0, CH
4154.4, C152.0, C149.9, C152.5, C
5155.0, C156.6, C (overlapped)155.7, C156.7, C
6110.0, CH104.1, CH104.4, CH104.6, CH
7127.6, CH125.7, CH125.5, CH126.4, CH
8114.2, CH117.0, CH120.9, CH116.7, CH
9133.3, C133.7, C134.7, C133.1, C
10114.8, C114.7, C114.3, C115.0, C
1′31.3, CH35.3, CH29.5, CH31.2, CH
2′35.0, CH241.7, CH234.8, CH235.4, CH2
3′66.8, CH71.8, CH67.3, CH66.8, CH
5′106.8, CH107.6, CH106.9, CH106.9, CH
6′127.7, CH127.1, CH (overlapped)127.8, CH127.6, CH
7′106.5, CH107.5, CH106.4, CH106.5, CH
8′155.7, C156.6, C155.7, C155.6, C
9′156.4, C158.0, C156.5, C156.6, C
10′110.6, C113.6, C110.5, C110.7, C
4/5-OMe56.1, OMe56.3, OMe56.3, OMe56.4, OMe
3′-Me21.0, CH321.1, CH321.3, CH321.1, CH3
Table 3. 1H and 13C NMR spectroscopic data of compounds 5 and 6 in CDCl3.
Table 3. 1H and 13C NMR spectroscopic data of compounds 5 and 6 in CDCl3.
Position56
δH (J in Hz)δCδH (J in Hz)δC
1-162.2, C--
26.47, d (8.4)108.9, CH4.06, dq (9.6, 6.0)71.1, CH
37.34, t (8.4)138.2, CH3.61, m71.2, CH
46.36, d (8.4)107.7, CH4.97, d (4.2)61.5, CH
4a-158.9, C-112.2, C
5α, 2.41, m; β, 1.39, m46.1, CH2-158.9, C
64.13, m66.0, CH6.47, d (8.4)102.4, CH
7α, 2.06, d (12.0)
β, 1.09, m
42.6, CH27.17, dd (8.4, 8.4)130.3, CH
81.86, m30.6, CH6.51, d (8.4)109.9, CH
8a1.85, br s58.5, CH-155.2, C
2-Me--1.49, d (6.0)17.6, CH3
5-OMe--3.88, s55.8, CH3
9-201.3, C--
9a-106.3, C--
10-81.3, C--
111.35, s24.4, CH3--
120.98, d (6.2)19.5, CH3--
1-OH11.59, s---
6-OH3.49, s---
Table 4. MIC values (µM) of antibacterial activity of compounds 13, 7, and 9.
Table 4. MIC values (µM) of antibacterial activity of compounds 13, 7, and 9.
CompoundsS. aureus
(ATCC 29213)
MRSA
(ATCC 700699)
MRSA
(ATCC 43300)
174.4--
274.4--
3148.8--
7-130.2390.6
9-131.6263.2
Vancomycin1.01.01.0
“-” signifies MIC > 500 μM, positive control: vancomycin.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yu, M.; Qiu, Y.; Chen, S.; Shi, J.; Gong, X.; Feng, J.; Lin, F.; Zeng, W.; Kang, W.; Zheng, C.; et al. New Bioactive Polyketides from the Mangrove-Derived Fungus Daldinia eschscholzii HJX1P2. Mar. Drugs 2025, 23, 238. https://doi.org/10.3390/md23060238

AMA Style

Yu M, Qiu Y, Chen S, Shi J, Gong X, Feng J, Lin F, Zeng W, Kang W, Zheng C, et al. New Bioactive Polyketides from the Mangrove-Derived Fungus Daldinia eschscholzii HJX1P2. Marine Drugs. 2025; 23(6):238. https://doi.org/10.3390/md23060238

Chicago/Turabian Style

Yu, Miao, Yikang Qiu, Shiji Chen, Jueying Shi, Xiu Gong, Jiayi Feng, Fangru Lin, Weinv Zeng, Wenyuan Kang, Caijuan Zheng, and et al. 2025. "New Bioactive Polyketides from the Mangrove-Derived Fungus Daldinia eschscholzii HJX1P2" Marine Drugs 23, no. 6: 238. https://doi.org/10.3390/md23060238

APA Style

Yu, M., Qiu, Y., Chen, S., Shi, J., Gong, X., Feng, J., Lin, F., Zeng, W., Kang, W., Zheng, C., & Huang, G. (2025). New Bioactive Polyketides from the Mangrove-Derived Fungus Daldinia eschscholzii HJX1P2. Marine Drugs, 23(6), 238. https://doi.org/10.3390/md23060238

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop